21 Nov 2008 CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
21 Nov 2008 RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis
20 Nov 2008 Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh- immunization Prevention Project
19 Nov 2008 Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
18 Nov 2008 Genentech Issues Dear Healthcare Provider Letter Regarding a 2nd Case of PML in a Raptiva Patient
18 Nov 2008 Cimzia(R) studies show significant clinical benefits for mono- and combination therapy in patients with rheumatoid arthritis
17 Nov 2008 Life Science Pharmaceuticals Enters Into Agreement with Abbott to Develop Antibody 806
13 Nov 2008 Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
13 Nov 2008 Antibody Shows Ability to Inhibit Disease in an Established RA Model
12 Nov 2008 Probiogen and Functional Genetics close antibody production agreement
12 Nov 2008 Functional Genetics and ProBioGen close antibody production agreement
11 Nov 2008 Phase 2 Study of IMC-1121B in First-Line Treatment of Advanced Non-Small Cell Lung Cancer Commences Patient Enrollment
11 Nov 2008 Celldex Announces Licensing Agreement for Novel Cancer Antibody Program
10 Nov 2008 Ophthotech Treats First Patient in a Phase I Trial of Monoclonal Antibody, Volociximab, for Age-Related Macular Degeneration
10 Nov 2008 Santaris Pharma Releases Positive Data on LNA-based Survivin Inhibitor
07 Nov 2008 InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
04 Nov 2008 YM Biosciences Reports Data From Exploratory Clinical Trials of Nimotuzumab in Brain Metastases and High-Grade Glioma Presentes at 2008 EORTC-NCI-AACR Annual Meeting
04 Nov 2008 Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
03 Nov 2008 Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
03 Nov 2008 CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
03 Nov 2008 Genentech Submits Application to U.S. Food and Drug Administration for Avastin in the Most Aggressive Form of Brain Cancer
01 Nov 2008 GlobeImmune Hepatitis C Therapeutic Vaccine, GI-5005, Doubles Viral Clearance and Increases RVR Rates in Phase 2 Clinical Trial
30 Oct 2008 New Cimzia(R) study shows rapid reduction of symptoms and progression of rheumatoid arthritis
30 Oct 2008 ERBITUX(R) Supplemental Biologics License Application for First-Line Recurrent or Metastatic Head and Neck Cancer Accepted for Priority Review by U.S. Food and Drug Administration
30 Oct 2008 Biogen Idec Elects to Participate with Genentech in the Development and Commercialization of a Next Generation Anti-CD20 Molecule

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up